Abiopharma

🔍 Simon Frederic (Executive)

Company: JFrog Ltd (FROG)

Report Date: 2026-08-13

Detailed Transactions and Holdings:

• Sold 4,900 shares of Ordinary Shares at $86.67 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,099,428.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 10,200 shares of Ordinary Shares at $87.63 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,089,228.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 26,242 shares of Ordinary Shares at $88.48 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,062,986.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 2,821 shares of Ordinary Shares at $89.36 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,060,165.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 31,160 shares of Ordinary Shares at $90.48 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,029,005.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 7,200 shares of Ordinary Shares at $91.38 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,021,805.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 4,793 shares of Ordinary Shares at $92.68 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,017,012.00 | transaction_form_type: 4 | Footnotes: F1, F8
• Sold 10,900 shares of Ordinary Shares at $93.82 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,006,112.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 21,284 shares of Ordinary Shares at $94.87 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,984,828.00 | transaction_form_type: 4 | Footnotes: F1, F10
• Sold 500 shares of Ordinary Shares at $95.42 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,984,328.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 12, 2025.
• F2: This transaction was executed in multiple trades at prices ranging from $85.98 to $86.97. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F3: This transaction was executed in multiple trades at prices ranging from $87.02 to $88.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F4: This transaction was executed in multiple trades at prices ranging from $88.02 to $89.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F5: This transaction was executed in multiple trades at prices ranging from $89.05 to $89.91. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F6: This transaction was executed in multiple trades at prices ranging from $90.05 to $90.95. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F7: This transaction was executed in multiple trades at prices ranging from $91.15 to $92.10. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F8: This transaction was executed in multiple trades at prices ranging from $92.21 to $93.18. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F9: This transaction was executed in multiple trades at prices ranging from $93.23 to $94.18. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F10: This transaction was executed in multiple trades at prices ranging from $94.24 to $95.20. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.